Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01143792 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Treatments for Homeless Youths
A Phase 2 study of Substance Abuse, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT01143792: Completed Phase 2 study of Substance Abuse, sponsored by Ohio State University.
NCT01143792 is a Phase 2 study of Substance Abuse that has completed, run by Ohio State University. The registered enrollment target is 270 participants, below the 5,255-participant average among 58 other Substance Abuse trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01143792, a Phase 2 study of Substance Abuse, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Youth who leave home for the streets are at significantly more risk for a multitude of problems, yet little research is available to guide treatment intervention efforts with this population. Studies document high rates of substance use, HIV risk, mental health problems, teenage pregnancy and criminality. Research to date examining homeless, street living youth has been primarily descriptive; less effort has been directed towards developing and evaluating treatment interventions for this group. The majority of homeless youth do not receive substance abuse treatment, with one study reporting that only 15% of street living youth report ever receiving mental health services. The effectiveness of the Community Reinforcement Approach (CRA) with street living youth was studied in our recently completed Stage 1 trial. The proposed study is a Stage II clinical trial examining outcome of CRA individual therapy as compared to two interventions commonly employed, yet little researched, with this group. All clients will be randomized to one of three theoretically distinct interventions: (1) CRA therapy, (2) Motivational Enhancement Therapy (MET), or (3) Case Management (CM). The relative effectiveness of these interventions will be evaluated at 3, 6, and 12 months post-baseline. The Social Ecology Theory of Development (Bronfenbrenner, 1979) guides our change hypotheses and intervention. Proposed change mechanisms (mediators) for each intervention will be evaluated. Differential treatment response as a function of ethnicity, gender, age, sexual orientation and abuse (moderators) will be investigated to better understand the interventions. The study will also examine how, if at all, treatment engagement, retention and expectations impact youth response to the three treatments. Information gained through this project may help address the gap in our understanding of how best to effectively intervene with a group at high risk for continuing health and psychological problems.
Primary Outcome
Percentage of substance use days in prior three months.
Conditions Studied
Interventions
- BEHAVIORAL Community Reinforcement Approach (CRA) + HIV prevention
- BEHAVIORAL Case Management + HIV Prevention
- BEHAVIORAL Motivational Enhancement Therapy (MET) + HIV prevention
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
What the finished NCT01143792 record still lists
NCT01143792 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 5,255-participant average among 58 other Substance Abuse trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 3 interventions - of which Community Reinforcement Approach (CRA) + HIV prevention is the first listed.
NCT01143792 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01143792 about?
NCT01143792 is a clinical study titled "Evaluation of Treatments for Homeless Youths". Youth who leave home for the streets are at significantly more risk for a multitude of problems, yet little research is available to guide treatment intervention efforts with this population. Studies document high rates of substance use, HIV risk, mental health problems, teenage pregnancy and crimin...
What is the current status of trial NCT01143792?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 270 participants. The study started on 2006-09. Estimated completion is 2012-06.
What conditions does trial NCT01143792 study?
This clinical trial studies the following conditions: Substance Abuse.
What interventions are being tested in trial NCT01143792?
The interventions under investigation include: Community Reinforcement Approach (CRA) + HIV prevention (BEHAVIORAL), Case Management + HIV Prevention (BEHAVIORAL), Motivational Enhancement Therapy (MET) + HIV prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01143792?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01143792 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01143792's enrollment target sits among peer trials
270 21st of 58 higher than 38 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes
COMPLETED · Phase 2
-
Substance Treatment and HIV Testing and Referral System
COMPLETED · Phase 2
-
Study of Medical Treatment for Methamphetamine Addiction
COMPLETED · Phase 2
-
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
COMPLETED · Phase 2
-
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
COMPLETED · Phase 2
-
Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia